Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea
- PMID: 22072854
- PMCID: PMC3208367
- DOI: 10.3748/wjg.v17.i37.4218
Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea
Abstract
Aim: To explore the value of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea.
Methods: Patients with acute infectious diarrhea ranging from 3 mo to 10 years in age were enrolled, and one to three stool samples from each subject were collected. Certain parameters, including white blood cells /differential count, C-reactive protein, fecal mucus, fecal pus cells, duration of fever, vomiting, diarrhea and severity (indicated by Clark and Vesikari scores), were recorded and analyzed. Fecal lactoferrin was determined by enzyme-linked immunosorbent assay and compared in different pathogen and disease activity. Generalized estimating equations (GEE) were also used for analysis.
Results: Data included 226 evaluations for 117 individuals across three different time points. Fecal lactoferrin was higher in patients with Salmonella (11.17 μg/g ± 2.73 μg/g) or Campylobacter (10.32 μg/g ± 2.94 μg/g) infections and lower in patients with rotavirus (2.82 μg/g ± 1.27 μg/g) or norovirus (3.16 μg/g ± 1.18 μg/g) infections. Concentrations of fecal lactoferrin were significantly elevated in patients with severe (11.32 μg/g ± 3.29 μg/g) or moderate (3.77 μg/g ± 2.08 μg/g) disease activity compared with subjects with mild (1.51 μg/g ± 1.36 μg/g) disease activity (P < 0.05). GEE analysis suggests that this marker could be used to monitor the severity and course of gastrointestinal infections and may provide information for disease management.
Conclusion: Fecal lactoferrin increased during bacterial infection and with greater disease severity and may be a good marker for predicting and monitoring intestinal inflammation in children with infectious diarrhea.
Keywords: Clark scores; Diarrhea; Generalized estimating equations; Lactoferrin; Vesikari scores.
Figures


Similar articles
-
Probiotic Lactobacillus casei: Effective for Managing Childhood Diarrhea by Altering Gut Microbiota and Attenuating Fecal Inflammatory Markers.Nutrients. 2019 May 23;11(5):1150. doi: 10.3390/nu11051150. Nutrients. 2019. PMID: 31126062 Free PMC article. Clinical Trial.
-
Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.J Pediatr Gastroenterol Nutr. 2012 Nov;55(5):541-7. doi: 10.1097/MPG.0b013e318262a718. J Pediatr Gastroenterol Nutr. 2012. PMID: 22699836
-
To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea.J Clin Microbiol. 1996 Apr;34(4):928-32. doi: 10.1128/jcm.34.4.928-932.1996. J Clin Microbiol. 1996. PMID: 8815110 Free PMC article.
-
The use of fecal calprotectin and lactoferrin in patients with IBD. Review.Acta Gastroenterol Belg. 2013 Sep;76(3):322-8. Acta Gastroenterol Belg. 2013. PMID: 24261027 Review.
-
Calprotectin or Lactoferrin: Do They Help.Dig Dis. 2016;34(1-2):98-104. doi: 10.1159/000442935. Epub 2016 Mar 16. Dig Dis. 2016. PMID: 26982329 Review.
Cited by
-
Probiotic Lactobacillus casei: Effective for Managing Childhood Diarrhea by Altering Gut Microbiota and Attenuating Fecal Inflammatory Markers.Nutrients. 2019 May 23;11(5):1150. doi: 10.3390/nu11051150. Nutrients. 2019. PMID: 31126062 Free PMC article. Clinical Trial.
-
Mitigating Diarrhoea-Related Inflammation in Frail Older Adults with Postbiotic-Enhanced Oral Rehydration Solution: Insights from a Randomised, Double-Blind, Placebo-Controlled Study.Geriatrics (Basel). 2025 Mar 1;10(2):34. doi: 10.3390/geriatrics10020034. Geriatrics (Basel). 2025. PMID: 40126284 Free PMC article.
-
Clinical Significance of Fecal Lactoferrin and Multiplex Polymerase Chain Reaction in Patients with Acute Diarrhea.Gut Liver. 2015 Sep 23;9(5):636-40. doi: 10.5009/gnl14106. Gut Liver. 2015. PMID: 25473075 Free PMC article.
-
Serum/Faecal S100A12, CRP and lactoferrin can be used to distinguish ınfectious and non-ınfectious canine diarrhoea.Vet Med Sci. 2023 Nov;9(6):2485-2496. doi: 10.1002/vms3.1245. Epub 2023 Sep 9. Vet Med Sci. 2023. PMID: 37688789 Free PMC article.
-
Combating Childhood Infections in LMICs: evaluating the contribution of Big Data Big data, biomarkers and proteomics: informing childhood diarrhoeal disease management in Low- and Middle-Income Countries.EBioMedicine. 2021 Nov;73:103668. doi: 10.1016/j.ebiom.2021.103668. Epub 2021 Nov 3. EBioMedicine. 2021. PMID: 34742129 Free PMC article.
References
-
- Miyauchi H, Hashimoto S, Nakajima M, Shinoda I, Fukuwatari Y, Hayasawa H. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain. Cell Immunol. 1998;187:34–37. - PubMed
-
- Curran CS, Demick KP, Mansfield JM. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell Immunol. 2006;242:23–30. - PubMed
-
- Ellison RT. The effects of lactoferrin on gram-negative bacteria. Adv Exp Med Biol. 1994;357:71–90. - PubMed
-
- Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem. 1999;74:486–498. - PubMed
-
- Crouch SP, Slater KJ, Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood. 1992;80:235–240. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials